RxDoctor Payments Data
★ My doctorsLook up a doctor →

John Seeley

Neurology · Overland Park, KSNPI 1649207135

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 761 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 50 manufacturers, the largest accounting for just 9.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,547 and has fallen 91.9% since, to $287 in 2023.

$10,641in general payments, 2019–2025

Across 761 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • AbbVie$916
  • Novartis$816
  • Biogen$631
  • EMD Serono, Inc.$576
  • Sanofi$517
  • plus $6K from 44 others

What the payments were for

  • Speaking & faculty fees$1261%
  • Food & beverage$10,51599%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.129$1,010
AbbVie(2 entities)68$916
Novartis56$816
Biogen37$631
EMD Serono, Inc.42$576
Sanofi30$517
UCB, Inc.29$454
Amgen31$430
Lilly USA, LLC22$350
Genentech USA, Inc.24$342
AstraZeneca17$341
Neurocrine Biosciences, Inc.16$265
Grifols USA, LLC10$248
Acadia Pharmaceuticals Inc13$229
SK Life Science, Inc.13$224
Amneal Pharmaceuticals LLC15$219
Lundbeck LLC14$218
Supernus Pharmaceuticals, Inc.13$208
Jazz Pharmaceuticals Inc.12$199
Catalyst Pharmaceuticals, Inc.10$189
Bristol Myers Squibb9$170
Upsher-smith Laboratories LLC7$156
Sunovion Pharmaceuticals Inc.10$147
Biohaven Pharmaceuticals, Inc.28$142
Kyowa Kirin, Inc.9$141
Biohaven Pharmaceutical Holding Company Ltd.20$127
Acorda Therapeutics, Inc7$126
Greenwich Biosciences, Inc.5$124
Banner Life Sciences, LLC5$117
Johnson & Johnson6$112
Arbor Pharmaceuticals, Inc.7$109
CSL Behring5$106
Zyla Life Sciences, Inc.6$91
Alnylam Pharmaceuticals Inc.5$89
Argenx US, Inc.3$57
GRT US Holding, Inc.3$51
Livanova USA, Inc.2$49
Assertio Therapeutics, Inc.3$44
Eisai Inc.3$37
Aquestive Therapeutics, Inc.2$37
Adamas Pharmaceuticals, Inc.2$35
Neurelis, Inc.2$32
Corium, LLC2$32
Xeris Pharmaceuticals, Inc.2$29
Promius Pharma LLC2$29
Almatica Pharma LLC1$17
Aprecia Pharmaceuticals, LLC1$16
Currax Pharmaceuticals LLC1$14
Mallinckrodt Enterprises LLC1$12
Medtronic1$11

How this compares

$10,641 in reported general payments places this provider in the 80th percentile of 131 neurology providers in Kansas.

See all neurology providers in Kansas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam ErLevetiracetam14$2,283
Levetiracetam13$632
Lamotrigine16$327

Paid to pharmacies, not to this prescriber.

Other neurology in Overland Park

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →